Research Topics
| P W SerruysSummaryAffiliation: Erasmus MC Country: The Netherlands Publications
| Collaborators
|
Detail Information
Publications
Biolimus-eluting biodegradable polymer versus sirolimus-eluting permanent polymer stent performance in long lesions: results from the LEADERS multicentre trial substudyJoanna J Wykrzykowska
The Department of Interventional Cardiology Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands
EuroIntervention 5:310-7. 2009..In this substudy of the LEADERS trial, we compared the performance of biolimus biodegradable polymer (BES) and sirolimus permanent polymer stents (SES) in long lesions...
Effects of the direct lipoprotein-associated phospholipase A(2) inhibitor darapladib on human coronary atherosclerotic plaquePatrick W Serruys
Thoraxcenter, Ba583, Erasmus MC, Rotterdam, Netherlands
Circulation 118:1172-82. 2008....
Impact of overlapping newer generation drug-eluting stents on clinical and angiographic outcomes: pooled analysis of five trials from the international Global RESOLUTE ProgramVasim Farooq
Interventional Cardiology Department, Erasmus MC, s Gravendijkwal 230, Rotterdam 3015 CE, The Netherlands
Heart 99:626-33. 2013....
Clinical and intravascular imaging outcomes at 1 and 2 years after implantation of absorb everolimus eluting bioresorbable vascular scaffolds in small vessels. Late lumen enlargement: does bioresorption matter with small vessel size? Insight from the ABSORoberto Diletti
Department of Interventional Cardiology, Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands
Heart 99:98-105. 2013..Therefore, we investigated the impact of vessel size on long-term outcomes, after Absorb BVS implantation...
Different cardiac biomarkers to detect peri-procedural myocardial infarction in contemporary coronary stent trials: impact on outcome reportingPascal Vranckx
Department of Cardiac Intensive Care and Interventional Cardiology, Hartcentrum Hasselt, Hasselt, Belgium
Heart 98:1424-30. 2012..To assess the differential implications of cardiac biomarker type on peri-procedural myocardial infarction (PMI) reporting...
A global risk approach to identify patients with left main or 3-vessel disease who could safely and efficaciously be treated with percutaneous coronary intervention: the SYNTAX Trial at 3 yearsPatrick W Serruys
Department of Interventional Cardiology, Erasmus University, Medical Centre, Thoraxcenter, Rotterdam, The Netherlands
JACC Cardiovasc Interv 5:606-17. 2012....
Quantitative multi-modality imaging analysis of a fully bioresorbable stent: a head-to-head comparison between QCA, IVUS and OCTJuan Luis Gutiérrez-Chico
Erasmus Medical Centre, Thoraxcenter, Ba583a, s Gravendijkwal 230, 3015 CE Rotterdam, The Netherlands
Int J Cardiovasc Imaging 28:467-78. 2012..Volumetric calculations using solid state IVUS are therefore not reliable. There is poor agreement for MLA estimation between all the imaging modalities studied, including IVUS-OCT, hence their values are not interchangeable...
Evaluation with in vivo optical coherence tomography and histology of the vascular effects of the everolimus-eluting bioresorbable vascular scaffold at two years following implantation in a healthy porcine coronary artery model: implications of pilot resuBill D Gogas
Thoraxcenter, Erasmus University Medical Centre, s Gravendijkwaal 230, 3015 Rotterdam, The Netherlands
Int J Cardiovasc Imaging 28:499-511. 2012..However, histology systematically gives larger values for all the measured structures compared to OCT, at 2 years post implantation...
Effect of clopidogrel discontinuation at 1 year after drug eluting stent placement on soluble CD40L, P-selectin and C-reactive protein levels: DECADES (Discontinuation Effect of Clopidogrel After Drug Eluting Stent): a multicenter, open-label studyJoanna J Wykrzykowska
Interventional Cardiology, Thoraxcenter, Erasmus MC, University Medical Center, s Gravendijkwal 230, 3015CE, Rotterdam, The Netherlands
J Thromb Thrombolysis 28:410-7. 2009..The latter hypothesis may be less likely given decrease in hsCRP levels. Randomized studies are urgently needed to establish potential link of clopidogrel discontinuation and vascular outcomes...
Utilizing risk scores in determining the optimal revascularization strategy for complex coronary artery diseaseVasim Farooq
Department of Interventional Cardiology, Erasmus University Medical Centre, Thoraxcenter, s Gravendijkwal 230, 3015 CE Rotterdam, The Netherlands
Curr Cardiol Rep 13:415-23. 2011..The emerging concepts of the patient-empowered risk/benefit tradeoff between PCI and CABG to help personalize the choice of revascularization modality are also explored...
Simulation of stent deployment in a realistic human coronary arteryFrank J H Gijsen
Department of Biomedical Engineering, Thoraxcentre EE2322, Erasmus Medical Center Rotterdam, P O Box 2040, 3000 CA, Rotterdam, The Netherlands
Biomed Eng Online 7:23. 2008..The knowledge of these parameters after stent deployment in a patient derived 3D reconstruction of a diseased coronary artery might give insights in the understanding of the process of restenosis...
Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery diseasePatrick W Serruys
Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands
N Engl J Med 360:961-72. 2009..Our trial compared PCI and CABG for treating patients with previously untreated three-vessel or left main coronary artery disease (or both)...
Sirolimus-eluting stents, bare metal stents or coronary artery bypass grafting for patients with multivessel disease including involvement of the proximal left anterior descending artery: analysis of the Arterial Revascularization Therapies study part 2 (N Kukreja
Thoraxcenter, Ba 583, s Gravendijkwal 230, Rotterdam 3015 CE, The Netherlands
Heart 95:1061-6. 2009..We therefore analysed the clinical outcome of patients in ARTS-I and ARTS-II with proximal LAD involvement...
Biodegradable stentsS Ramcharitar
Department of Interventional, Cardiology Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
Minerva Cardioangiol 56:205-13. 2008..Their behaviour will not only redefine current percutaneous coronary intervention but may also have a wider role in the cardiovascular system as whole...
Are drug-eluting stents associated with a higher rate of late thrombosis than bare metal stents? Late stent thrombosis: a nuisance in both bare metal and drug-eluting stentsPatrick W Serruys
Department of Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
Circulation 115:1433-9; discussion 1439. 2007
Fourth annual American College of Cardiology international lecture: a journey in the interventional fieldPatrick W Serruys
Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
J Am Coll Cardiol 47:1754-68. 2006
Clinical development of bivalirudin (Angiox): rationale for thrombin-specific anticoagulation in percutaneous coronary intervention and acute coronary syndromesP W Serruys
Department of Cardiology, Thoraxcentre, Erasmus MC, Cardialysis Clinical Research Management and Core Laboratories, Rotterdam, The Netherlands
Int J Clin Pract 60:344-50. 2006..This paper will discuss the clinical development of the direct thrombin inhibitor bivalirudin as the core anticoagulant in the contemporary PCI setting and the implications for its use in ACS...
Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trialPatrick W Serruys
Interventional Cardiology Department, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
J Am Coll Cardiol 46:575-81. 2005..The long-term (five-year) comparative results of treatment of multivessel coronary artery disease with stenting or coronary artery bypass grafting (CABG) is at present unknown...
The effect of variable dose and release kinetics on neointimal hyperplasia using a novel paclitaxel-eluting stent platform: the Paclitaxel In-Stent Controlled Elution Study (PISCES)Patrick W Serruys
Erasmus Medical Center, Rotterdam, The Netherlands
J Am Coll Cardiol 46:253-60. 2005..The aim of this study was to evaluate the effect of variable dose and release kinetics of paclitaxel on neointimal hyperplasia...
Actinomycin-eluting stent for coronary revascularization: a randomized feasibility and safety study: the ACTION trialPatrick W Serruys
Erasmus Medical Center, Rotterdam, The Netherlands
J Am Coll Cardiol 44:1363-7. 2004..We sought to demonstrate the safety and performance of the actinomycin D-coated Multilink-Tetra stent(Guidant Corp., Santa Clara, California) in the treatment of patients with single de novo native coronary lesions...
A European multi-center trial investigating the anti-restenotic effect of intravascular sonotherapy after stenting of de novo lesions (EUROSPAH: EUROpean Sonotherapy Prevention of Arterial Hyperplasia)P W Serruys
Thoraxcentre, Rotterdam, The Netherlands
Int J Cardiovasc Intervent 6:53-60. 2004..Intravascular sonotherapy (IST) reduces neointimal hyperplasia post-stenting in animal studies. Euro-SPAH is a multi-center, double blind, randomized trial investigating the efficacy of IST to reduce in-stent late loss...
Direct stenting versus direct stenting followed by centered beta-radiation with intravascular ultrasound-guided dosimetry and long-term anti-platelet treatment: results of a randomized trial: Beta-Radiation Investigation with Direct Stenting and Galileo iPatrick W Serruys
Erasmus Medical Center, Rotterdam, The Netherlands
J Am Coll Cardiol 44:528-37. 2004..We sought to assess the efficacy of vascular brachytherapy (VBT) combined with stenting for the primary prevention of restenosis...
Sirolimus eluting stent implantation for patients with multivessel disease: rationale for the Arterial Revascularisation Therapies Study part II (ARTS II)P W Serruys
Erasmus Medical Center, Thoraxcenter, Rotterdam, The Netherlands
Heart 90:995-8. 2004
Vascular responses at proximal and distal edges of paclitaxel-eluting stents: serial intravascular ultrasound analysis from the TAXUS II trialPatrick W Serruys
Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands
Circulation 109:627-33. 2004..We used serial intravascular ultrasound (IVUS) to prospectively analyze vessel responses in adjacent reference segments after implantation of polymer-controlled paclitaxel-eluting stents...
Effect of an anti-PDGF-beta-receptor-blocking antibody on restenosis in patients undergoing elective stent placementPatrick W Serruys
Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands
Int J Cardiovasc Intervent 5:214-22. 2003..The aim of the study was to determine whether a single intravenous infusion of 25 mg/kg CDP860, a humanized di-Fab' fragment against PDGF-beta receptor, leads to a reduction of in-stent restenosis...
Assessment of the SYNTAX score in the Syntax studyPatrick W Serruys
Department of Interventional Cardiology, Erasmus Medical Center, Thoraxcenter Rotterdam, The Netherlands
EuroIntervention 5:50-6. 2009....
5-year clinical outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the sirolimus-eluting stent in the treatment of patients with multivessel de novo coronary artery lesionsPatrick W Serruys
Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
J Am Coll Cardiol 55:1093-101. 2010....
Contemporary and evolving risk scoring algorithms for percutaneous coronary interventionVasim Farooq
Department of Interventional Cardiology, Erasmus University Medical Centre, Thoraxcenter, Rotterdam, The Netherlands
Heart 97:1902-13. 2011....
Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: 12-month clinical and imaging outcomesPatrick W Serruys
Thorax Center, Erasmus Medical Center, Gravendijkwal 230, Rotterdam, The Netherlands
J Am Coll Cardiol 58:1578-88. 2011..The aim of this study was to demonstrate that the prevention of early scaffold area shrinkage of the ABSORB BVS (Rev.1.1, Abbott Vascular, Santa Clara, California) was sustained and not simply delayed by a few months...
Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomesPatrick W Serruys
Thoraxcenter, Ba 583, s Gravendijkwal 230, 3015 CE Rotterdam, The Netherlands
Circulation 122:2301-12. 2010..Nevertheless, late luminal loss was less than that observed with bare metal stents. To maintain the mechanical integrity of the device up to 6 months, the scaffold design and manufacturing process of its polymer were modified...
Comparison of zotarolimus-eluting and everolimus-eluting coronary stentsPatrick W Serruys
Department of Cardiology, Erasmus Medical Center, Molewaterplein 40, Ba 583, 3015 GD Rotterdam, The Netherlands
N Engl J Med 363:136-46. 2010..However, it is unclear whether there are differences in efficacy and safety between the two types of stents on the basis of prospectively adjudicated end points endorsed by the Food and Drug Administration...
Three-year results of clinical follow-up after a bioresorbable everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB trialYosinobu Onuma
Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
EuroIntervention 6:447-53. 2010..Nevertheless, the long-term safety and efficacy of this novel therapy remain to be documented...
Four-year clinical outcome of sirolimus- and paclitaxel-eluting stents compared to bare-metal stents for the percutaneous treatment of stable coronary artery diseaseCihan Simsek
Department of Cardiology, Thoraxcenter, Erasmus Medical Center Rotterdam, Dr Molewaterplein 40, Rotterdam, The Netherlands
Catheter Cardiovasc Interv 76:41-9. 2010..There are limited data on the long-term safety and efficacy profile of coronary stent implantation in patients with stable coronary artery disease (CAD) undergoing percutaneous coronary intervention (PCI)...
A randomised comparison of novolimus-eluting and zotarolimus-eluting coronary stents: 9-month follow-up results of the EXCELLA II studyPatrick W Serruys
Erasmus Medisch Centrum, Rotterdam, The Netherlands
EuroIntervention 6:195-205. 2010..Novolimus, a macrocyclic lactone with anti-proliferative properties, has a similar efficacy to currently available agents; however it requires a lower dose, and less polymer, and is therefore conceivably safer...
Intracoronary optical coherence tomography and histology at 1 month and 2, 3, and 4 years after implantation of everolimus-eluting bioresorbable vascular scaffolds in a porcine coronary artery model: an attempt to decipher the human optical coherence tomoYoshinobu Onuma
Thoraxcenter, Erasmus University Medical Center, Rotterdam, The Netherlands
Circulation 122:2288-300. 2010..We therefore report OCT findings with corresponding histology in the porcine coronary artery model immediately after and at 28 days and 2, 3, and 4 years after BVS implantation...
Radioactive stents delay but do not prevent in-stent neointimal hyperplasiaI P Kay
Thoraxcenter, University Hospital Rotterdam, Dijkzigt, The Netherlands
Circulation 103:14-7. 2001..Clinical outcome 1 year after the implantation of stents with an initial activity of 6 to 12 microCi is not favorable when compared with conventional stenting...
"Edge Effect" of (32)p radioactive stents is caused by the combination of chronic stent injury and radioactive dose falloffW J van der Giessen
Department of Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
Circulation 104:2236-41. 2001....
Geographical miss during catheter-based intracoronary beta-radiation: incidence and implications in the BRIE study. Beta-Radiation In EuropeG Sianos
Department of Cardiology, Thoraxcenter, Erasmus Medical Center Rotterdam, The Netherlands
J Am Coll Cardiol 38:415-20. 2001..6%, respectively, p = 0.8). CONCLUSIONS: Geographical miss is strongly associated with restenosis at the edges of the EIRS. This effect is more prominent when caused by stenting. Geographical miss does not increase restenosis in the EIRS...
Value of coronary stenotic flow velocity acceleration in prediction of angiographic restenosis following balloon angioplastyM Albertal
Interventional Cardiology, Hartcentrum, Thoraxcenter, Academisch Ziekenhuis Rotterdam, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands
Eur Heart J 23:1849-53. 2002..CONCLUSION: Following angioplasty, SV appears to be exquisitely sensitive to the changes experienced at the treated area without depending on the status of the microcirculation...
Value of coronary stenotic flow velocity acceleration on the prediction of long-term improvement in functional status after angioplastyM Albertal
Thoraxcenter, Amsterdam, The Netherlands
Am Heart J 142:81-6. 2001..03 to 1.07) were associated with a lack of improvement at follow-up. CONCLUSIONS: The detection of SVA was associated with failure of improvement in functional activity at follow-up after coronary intervention...
Coronary restenosis elimination with a sirolimus eluting stent: first European human experience with 6-month angiographic and intravascular ultrasonic follow-upB J Rensing
Department of Interventional Cardiology, Thoraxcenter, Rotterdam, The Netherlands
Eur Heart J 22:2125-30. 2001..3 mm(3)and 1.8%, respectively. No edge effect was observed in the segments proximal and distal to the stents. CONCLUSION: Implantation of a sirolimus-eluting stent seems to effectively prevent intimal hyperplasia...
Clinical and angiographical follow-up after implantation of a 6--12 microCi radioactive stent in patients with coronary artery diseaseA J Wardeh
Thoraxcenter Rotterdam, University Hospital Rotterdam, Dijkzigt, The Netherlands
Eur Heart J 22:669-75. 2001..30+/-0.53 (stent area). CONCLUSION: These results indicate that the use of radioactive stents is safe and feasible, however, the high incidence of edge restenosis makes this technique currently clinically non-applicable...
Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II)P W Serruys
University Hospital Rotterdam Dijkzigt, Thorax Center, Rotterdam, The Netherlands
Lancet 352:673-81. 1998....
The pattern of restenosis and vascular remodelling after cold-end radioactive stent implantationI P Kay
Thoraxcenter, Rotterdam, The Netherlands
Eur Heart J 22:1311-7. 2001..0%) and 11.4 mm3 (25.6%), respectively (P=0.017). At the stent edges there was no significant change in lumen volume. CONCLUSIONS: Cold-end stenting results in increased neointimal hyperplasia in in-stent non-radioactive segments...
True 3-dimensional reconstruction of coronary arteries in patients by fusion of angiography and IVUS (ANGUS) and its quantitative validationC J Slager
Thoraxcenter, University Hospital Rotterdam Dijkzigt, Erasmus University Rotterdam, Utrecht, Netherlands
Circulation 102:511-6. 2000..84 to 0.97) with corresponding measurements in the actual biplane angiographic images. CONCLUSIONS: With ANGUS, 3D reconstructions of coronary arteries can be successfully and accurately obtained in the majority of patients...
Comparison of brachytherapy strategies based on dose-volume histograms derived from quantitative intravascular ultrasoundS G Carlier
Department of Interventional Cardiology, Thoraxcenter, Erasmus University Rotterdam, The Netherlands
Cardiovasc Radiat Med 1:115-24. 1999..This paper discusses the potential merits of dose-volume histograms (DVH) based on three-dimensional (3-D) reconstruction of electrocardiogram (ECG)-gated intravascular ultrasound (IVUS) to compare brachytherapy treatment strategies...
One year clinical follow up of paclitaxel eluting stents for acute myocardial infarction compared with sirolimus eluting stentsS H Hofma
Thoraxcentre, Erasmus Medical Centre, Rotterdam, The Netherlands
Heart 91:1176-80. 2005..Bifurcation stenting in acute myocardial infarction should, if possible, be avoided because of the increased risk of stent thrombosis...
Long term outcome after intracoronary beta radiation therapyG Sianos
Department of Interventional Cardiology, Thoraxcentre, Erasmus MC, Rotterdam, The Netherlands
Heart 91:942-7. 2005..To determine the long term outcome after intracoronary beta radiation therapy (IRT)...
Long-term clinical outcome after coronary balloon angioplasty: identification of a population at low risk of recurrent events during 17 years of follow-upR T van Domburg
The Department of Cardiac Catheterization and Interventional Cardiology, Thoraxcenter, Erasmus University and University Hospital Dijkzigt Rotterdam, The Netherlands
Eur Heart J 22:934-41. 2001....
Stenting with a true bifurcated stent: acute and mid-term follow-up resultsS G Carlier
Interventional Department, Rotterdam Heart Center, Thoraxcenter, Rotterdam, The Netherlands
Catheter Cardiovasc Interv 47:361-96. 1999..Cathet. Cardiovasc. Intervent. 47:361-369, 1999...
Long-term clinical results following stenting of the left main stem: insights from RESEARCH (Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated at Rotterdam Cardiology Hospital) RegistriesYoshinobu Onuma
Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
JACC Cardiovasc Interv 3:584-94. 2010....
Quantitative measurements of in-stent restenosis: A comparison between quantitative coronary ultrasound and quantitative coronary angiographyN Bruining
Thoraxcenter, Department of Cardiology, Erasmus Medical Center and Erasmus University, Rotterdam, The Netherlands
Catheter Cardiovasc Interv 48:133-42. 1999..This is of particular relevance to quantitative studies addressing absolute changes in vascular or luminal diameters. Cathet. Cardiovasc. Intervent. 48:133-142, 1999...
Methodological considerations and approach to cross-technique comparisons using in vivo coronary plaque characterization based on intravascular ultrasound radiofrequency data analysis: insights from the Integrated Biomarker and Imaging Study (IBIS)G A Rodriguez-Granillo
Erasmus Medical Center, Thoraxcenter, Rotterdam, The Netherlands
Int J Cardiovasc Intervent 7:52-8. 2005..IVUS-VH was not included at the start of the IBIS protocol. The purpose of this paper is to describe the methodology we used to obtain and analyse IVUS-VH images and the approach to cross-correlations with the other techniques...
Guidance of intracoronary radiation therapy based on dose-volume histograms derived from quantitative intravascular ultrasoundS G Carlier
Department of Intervention Cardiology, Thoraxcentre, Erasmus University Rotterdam, The Netherlands
IEEE Trans Med Imaging 17:772-8. 1998..5) conducted in our institution are presented, supporting the use of DVH based on quantitative IVUS measurements for optimal dose prescription in vascular interventional radiation therapy...
Routine sirolimus eluting stent implantation for unselected in-stent restenosis: insights from the rapamycin eluting stent evaluated at Rotterdam Cardiology Hospital (RESEARCH) registryF Saia
Department of Invasive Cardiology, Thoraxcentre, Erasmus University Medical Centre, Rotterdam, The Netherlands
Heart 90:1183-8. 2004..6% (n = 5). CONCLUSIONS: Routine SES implantation is highly effective for focal in-stent restenosis and appears to be a promising strategy for more complex patterns of restenosis...
Five-year clinical outcomes after coronary stenting of chronic total occlusion using sirolimus-eluting stents: insights from the rapamycin-eluting stent evaluated at Rotterdam Cardiology Hospital-(Research) RegistryZhu jun Shen
Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
Catheter Cardiovasc Interv 74:979-86. 2009..The objective of this report was to evaluate the outcomes of these patients at 5-years clinical follow-up...
Lowering the dose of sirolimus, released from a nonpolymeric hydroxyapatite coated coronary stent, reduces signs of delayed healingWim J van der Giessen
Department of Cardiology, Erasmus Medical Center, Rotterdam, The Netherlands
JACC Cardiovasc Interv 2:284-90. 2009....
Acute coronary syndromes: an emphasis shift from treatment to prevention; and the enduring challenge of vulnerable plaque detection in the cardiac catheterization laboratoryMarco Valgimigli
Thoraxcentre, Erasmus MC, Rotterdam, The Netherlands
J Cardiovasc Med (Hagerstown) 8:221-9. 2007..Thus, a combination of several modalities will be important in the future to ensure a high sensitivity and specificity in detecting vulnerable plaques...
Incidence, predictors, and significance of abnormal cardiac enzyme rise in patients treated with bypass surgery in the arterial revascularization therapies study (ARTS)M A Costa
University Hospital Dijkzigt, Thoraxcentrum, Rotterdam, The Netherlands
Circulation 104:2689-93. 2001....
Optical coherence tomography assessment of the acute effects of stent implantation on the vessel wall: a systematic quantitative approachN Gonzalo
Thoraxcenter, Erasmus MC, 3015 CE Rotterdam, The Netherlands
Heart 95:1913-9. 2009....
The immediate and long-term effect of optimal balloon angioplasty on the absolute coronary blood flow velocity reserve. A subanalysis of the DEBATE study. Doppler Endpoints Balloon Angioplasty Trial EuropeJ J Piek
Department of Cardiology, Academical Medical Center, Amsterdam, The Netherlands
Eur Heart J 22:1725-32. 2001..Coronary flow reserve alterations in patients without restenosis were related to changes in hyperaemic blood flow velocity, suggesting that this phenomenon relates to epicardial remodelling...
True reconstruction of vessel geometry from combined X-ray angiographic and intracoronary ultrasound dataC J Slager
Thoraxcenter, University Hospital Rotterdam Dijkzigt, The Netherlands
Semin Interv Cardiol 2:43-7. 1997..Application of such a method will be helpful to understand immediate and long-term vessel remodelling induced by all types of catheter interventions and in the study of progression or regression of atherosclerotic wall disease...
The influence of stent length on clinical and angiographic outcome in patients undergoing elective stenting for native coronary artery lesions; final results of the Magic 5L StudyD P Foley
Interventional Cardiology, Thoraxcentre Bd 414, Academic Hospital Rotterdam, Dr Molewaterplein 40, 3015 GD Rotterdam, Netherlands
Eur Heart J 22:1585-93. 2001..Long coronary lesions provide a challenging substrate for emerging antirestenosis therapies, such as stent coatings and brachytherapy...
Three-year clinical outcomes after coronary stenting of chronic total occlusion using sirolimus-eluting stents: insights from the rapamycin-eluting stent evaluated at Rotterdam cardiology hospital-(RESEARCH) registryHector M Garcia Garcia
Thoraxcenter, Erasmus Medical Center, Rotterdam, Netherlands
Catheter Cardiovasc Interv 70:635-9. 2007..There are currently no long-term results of the efficacy of SES in this subset of lesions. We assessed the 3-year clinical outcomes of 147 patients with CTO treated with either SES or bare metal stents (BMS)...
Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantationAndrew T L Ong
Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
J Am Coll Cardiol 45:947-53. 2005..Stent thrombosis was associated with a high morbidity and mortality. Bifurcation stenting, when performed in patients with acute myocardial infarction, was associated with an increased risk of ST...
Characterization of plaque components and vulnerability with intravascular ultrasound elastographyC L de Korte
Erasmus University, Rotterdam, The Netherlands
Phys Med Biol 45:1465-75. 2000..Intravascular elastography provides information that is frequently unavailable or inconclusive from the IVUS image and which may therefore assist in the diagnosis and treatment of atherosclerotic disease...
[Sirolimus-releasing coronary stent: lessons from the Rotterdam experience]P A Lemos
Thoraxcenter, , Rotterdam, Pays-Bas
Ann Cardiol Angeiol (Paris) 53:32s-35s. 2004
Acute and 6-month clinical and angiographic outcome after implantation of the ACS Duet stent for single-vessel coronary artery disease: final results of the European and US ACS Multi-link Duet RegistryD P Foley
Department of Interventional Cardiology Thoraxcenter, Erasmus University Medical Center, Rotterdam, The Netherlands
Catheter Cardiovasc Interv 54:25-33. 2001..With late outcomes at least comparable to the best published results, this stent platform provides safe and effective percutaneous treatment of obstructive coronary artery disease. Cathet Cardiovasc Intervent 2001;54:25-33...
Clinical and angiographic outcome of patients with mild coronary lesions treated with balloon angioplasty or coronary stenting. Implications for mechanical plaque sealingN Mercado
Thoraxcentre, University Hospital Dijkzigt, Rotterdam, The Netherlands
Eur Heart J 24:541-51. 2003..Moreover, major adverse cardiac events at 1-year after PCI are not directly related to the degree of pre-procedural stenosis severity...
Sirolimus eluting stent in the treatment of atherosclerosis coronary artery diseaseM Degertekin
Department of Interventional Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
Minerva Cardioangiol 50:405-18. 2002..As compare with standard coronary stent, a sirolimus-eluting stent shows considerable promise for the prevention of neointimal proliferation, restenosis and associated clinical events...
Clinical and quantitative coronary angiographic predictors of coronary restenosis: a comparative analysis from the balloon-to-stent eraN Mercado
Thoraxcenter, University Hospital Dijkzigt, Rotterdam, The Netherlands
J Am Coll Cardiol 38:645-52. 2001..Still important, but more so in the stent population, is a large post-MLD (optimal result). Finally, a larger pre-RD became a favorable predictor with the advent of stenting...
Long term outcome after coronary stent implantation: a 10 year single centre experience of 1000 patientsR T van Domburg
Department of Cardiac Catheterization and Interventional Cardiology, Erasmus University and University Hospital Rotterdam, Thoraxcenter, Bd 308, Dr Molewaterplein 40, 3015 GD, Rotterdam, Netherlands
Heart 82:II27-34. 1999..To describe the long term clinical outcome (up to 11 years) after coronary stenting...
Comparison of three-year clinical outcome of sirolimus- and paclitaxel-eluting stents versus bare metal stents in patients with ST-segment elevation myocardial infarction (from the RESEARCH and T-SEARCH Registries)Joost Daemen
Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
Am J Cardiol 99:1027-32. 2007..A high frequency of stent thrombosis was observed in the 2 drug-eluting stent groups...
Persistent inhibition of neointimal hyperplasia after sirolimus-eluting stent implantation: long-term (up to 2 years) clinical, angiographic, and intravascular ultrasound follow-upMuzaffer Degertekin
Thoraxcenter, Erasmus University Medical Center, Rotterdam, The Netherlands
Circulation 106:1610-3. 2002..CONCLUSION: Sirolimus-eluting stents showed persistent inhibition of neointimal hyperplasia for up to 2 years of follow-up...
Fate of side branches after coronary arterial sirolimus-eluting stent implantationKengo Tanabe
Thoraxcenter, Rotterdam, The Netherlands
Am J Cardiol 90:937-41. 2002..Thus, the fate of side branches after SES implantation is favorable and at least as good as after UMS implantation...
Impact of vessel size on angiographic and clinical outcomes of revascularization with biolimus-eluting stent with biodegradable polymer and sirolimus-eluting stent with durable polymer the LEADERS trial substudyJoanna J Wykrzykowska
Department of Interventional Cardiology Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
JACC Cardiovasc Interv 2:861-70. 2009..We assessed the impact of vessel size on outcomes of stenting with biolimus-eluting degradable polymer stent (BES) and sirolimus-eluting permanent polymer stent (SES) within a randomized multicenter trial (LEADERS)...
Initial observation regarding changes in vessel dimensions after balloon angioplasty and stenting followed by catheter-based beta-radiation. Is stenting necessary in the setting of catheter-based radiotherapy?K Kozuma
Department of Cardiology, Thoraxcentre, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands
Eur Heart J 23:641-9. 2002..We sought to compare the effect of intracoronary beta-radiation on the vessel dimensions in de novo lesions using three-dimensional intravascular ultrasound quantification after balloon angioplasty and stenting...
Advancing intravascular ultrasonic palpation toward clinical applicationsM M Doyley
Thoraxcentre, Erasmus University, Rotterdam 3000 DR The Netherlands
Ultrasound Med Biol 27:1471-80. 2001..Although the clinical results are clearly preliminary, it was concluded that the prototype system performed sufficiently well to warrant further and more in-depth clinical investigation...
The TRAPIST Study. A multicentre randomized placebo controlled clinical trial of trapidil for prevention of restenosis after coronary stenting, measured by 3-D intravascular ultrasoundP W Serruys
Department of Interventional Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
Eur Heart J 22:1938-47. 2001..29). CONCLUSION: Oral trapidil 600 mg daily for 6 months did not reduce in-stent hyperplasia or improve clinical outcome after successful Wallstent implantation and is not indicated for this purpose...
Stent development and local drug deliveryE Regar
Department of Cardiology, Thoraxcentre, Erasmus Medical Centre Rotterdam, The Netherlands
Br Med Bull 59:227-48. 2001..The clinical benefit of these approaches still has to be proven...
Flow estimation using an intravascular imaging catheterA F van der Steen
Thorax Centre, Erasmus University, Rotterdam, The Netherlands
Ultrasonics 38:363-8. 2000..Although the principle is the same, the method needs some adaptation through the inherent different beamforming of the transducer. In this paper various aspects of the development of IVUS flow are reviewed...
Improvement of left ventricular contractility and relaxation with the beta 1-adrenergic receptor partial agonist xamoterol at rest and during exercise in patients with postinfarction left ventricular dysfunction. A placebo-controlled randomized trialP J de Feyter
Catheterization Laboratory, Thoraxcenter, Erasmus University, Rotterdam, The Netherlands
Circulation 81:III99-106. 1990..Thus, xamoterol can be a useful addition for the treatment of left ventricular dysfunction because of long-term ischemic heart disease...
Periprocedural quantitative coronary angiography after Palmaz-Schatz stent implantation predicts the restenosis rate at six months: results of a meta-analysis of the BElgian NEtherlands Stent study (BENESTENT) I, BENESTENT II Pilot, BENESTENT II and MUSICP W Serruys
Department of Interventional Cardiology, Thoraxcenter, Academisch Ziekenhuis, Rotterdam, The Netherlands
J Am Coll Cardiol 34:1067-74. 1999..We aimed to identify periprocedural quantitative coronary angiographic (QCA) variables that have predictive value on long-term angiographic results and to construct multivariate models using these variables for postprocedural prognosis...
The relative safety and efficacy of bare-metal and drug-eluting stents in low and high-risk patient subsets. An epidemiological analysis of three sequential cohorts of consecutive all comers (n = 6129)Joost Daemen
Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
EuroIntervention 4:464-74. 2009..There is still limited data about the long-term safety and efficacy of DES in high-risk subgroups...
Usefulness of clinical, echocardiographic, and procedural characteristics to predict outcome after percutaneous transluminal septal myocardial ablationChris van der Lee
Department of Cardiology, Thoraxcenter, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands
Am J Cardiol 101:1315-20. 2008..Late PTSMA failure could not be predicted by baseline characteristics but could partially be explained by a learning-curve effect. This finding implies that PTSMA procedures should be restricted to experienced centers...
Computed tomography in total coronary occlusions (CTTO registry): radiation exposure and predictors of successful percutaneous interventionHector M Garcia-Garcia
Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
EuroIntervention 4:607-16. 2009..To define better the role of CTCA in the treatment of patients with CTOs, we performed CTCA in a consecutive cohort of eligible patients who were scheduled for percutaneous recanalisation of a CTO...
Post-sirolimus-eluting stent restenosis treated with repeat percutaneous intervention: late angiographic and clinical outcomesPedro A Lemos
Erasmus Medical Center, Thoraxcenter, Rotterdam, The Netherlands
Circulation 109:2500-2. 2004....
Clinical and angiographic outcomes after overdilatation of undersized sirolimus-eluting stents with largely oversized balloons: an observational studyFrancesco Saia
Erasmus MC, Thoraxcenter, Rotterdam, The Netherlands
Catheter Cardiovasc Interv 61:455-60. 2004..13 +/- 0.34 and restenosis rate was 7.7%. Although not routinely recommended in every patient, SES postdilatation with largely oversized balloons appears a safe and effective strategy for selected patients...
Shear stress, vascular remodeling and neointimal formationJolanda J Wentzel
Department of Cardiology, Thoraxcentre EE2322, Erasmus Medical Centre Rotterdam, Erasmus University Rotterdam, P.O. Box 1738, 3000 DR Rotterdam, Netherlands
J Biomech 36:681-8. 2003..Attempts to locally increase shear stress by a newly developed flow divider indicate that shear stress reduce in-stent neointimal formation by 50%...
The risk of stent thrombosis in patients with acute coronary syndromes treated with bare-metal and drug-eluting stentsNeville Kukreja
Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
JACC Cardiovasc Interv 2:534-41. 2009..We aimed to evaluate the risk of definite stent thrombosis with bare-metal stents (BMS) and drug-eluting stents (DES) in patients treated for acute coronary syndromes...
Augmentation of wall shear stress inhibits neointimal hyperplasia after stent implantation: inhibition through reduction of inflammation?Stephane G Carlier
Thoraxcentre, Erasmus Medical Center Rotterdam, Netherlands
Circulation 107:2741-6. 2003..We studied the causal relationship between WSS and NH formation in stents by locally increasing WSS with a flow divider (Anti-Restenotic Diffuser, Endoart SA) placed in the center of the stent...
3-Dimensional bifurcation angle analysis in patients with left main disease: a substudy of the SYNTAX trial (SYNergy Between Percutaneous Coronary Intervention with TAXus and Cardiac Surgery)Chrysafios Girasis
Thoraxcenter, Erasmus University Medical Center, Rotterdam, The Netherlands
JACC Cardiovasc Interv 3:41-8. 2010..We explore the bifurcation angle (BA) parameters of the left main coronary artery (LM), the effect of percutaneous coronary intervention (PCI) on this angulation, and the impact of BA on clinical outcome...
Images in Cardiovascular Medicine. True three-dimensional reconstructed images showing lumen enlargement after sirolimus-eluting stent implantationKengo Tanabe
Division of Cardiology, Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands
Circulation 106:e179-80. 2002
Three-year clinical follow-up of the unrestricted use of sirolimus-eluting stents as part of the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) registryJoost Daemen
The Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
Am J Cardiol 98:895-901. 2006..The beneficial effects, reported after 1 and 2 years in reducing major adverse cardiac events, persisted with no evidence of a clinical late restenotic "catch-up" phenomenon...
Platelet GP IIb/IIIa receptor blockers for failed thrombolysis in acute myocardial infarction, alone or as adjunct to other rescue therapies; single centre retrospective analysis of 548 consecutive patients with acute myocardial infarctionE Ronner
Erasmus Medical Center, Rotterdam, The Netherlands
Eur Heart J 23:1529-37. 2002..Rescue therapy is a widely used strategy for failed thrombolysis, but is associated with a high bleeding rate. Alternative reperfusion strategies to avoid failed thrombolysis should be considered in high risk patients...
Multislice spiral computed tomography for the evaluation of stent patency after left main coronary artery stenting: a comparison with conventional coronary angiography and intravascular ultrasoundCarlos A G van Mieghem
Department of Cardiology, Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands
Circulation 114:645-53. 2006..MSCT is safe to exclude left main ISR and may therefore be an acceptable first-line alternative to CCA...
Long-term outcomes after stenting of bifurcation lesions with the "crush" technique: predictors of an adverse outcomeAngela Hoye
Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
J Am Coll Cardiol 47:1949-58. 2006..Furthermore, the incidence of possible stent thrombosis is of concern and requires further investigation. Kissing balloon post-dilatation is mandatory to reduce side branch restenosis...
Short- and long-term clinical outcome after drug-eluting stent implantation for the percutaneous treatment of left main coronary artery disease: insights from the Rapamycin-Eluting and Taxus Stent Evaluated At Rotterdam Cardiology Hospital registries (RESMarco Valgimigli
Erasmus Medical Center, Rotterdam, The Netherlands
Circulation 111:1383-9. 2005....
Two-year clinical, angiographic, and intravascular ultrasound follow-up of the XIENCE V everolimus-eluting stent in the treatment of patients with de novo native coronary artery lesions: the SPIRIT II trialBimmer E Claessen
Department of Cardiology, Academic Medical Center, University of Amsterdam, The Netherlands
Circ Cardiovasc Interv 2:339-47. 2009..This article reports the 2-year clinical, angiographic, and intravascular ultrasound outcomes of the everolimus-eluting stent (EES) compared with the paclitaxel-eluting stent (PES) in the randomized SPIRIT II trial...
Early and persistent intraventricular conduction abnormalities and requirements for pacemaking after percutaneous replacement of the aortic valveNicolo Piazza
Department of Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
JACC Cardiovasc Interv 1:310-6. 2008..In this retrospective study, we examined the incidence of post-procedural conduction abnormalities and the need for pacing in patients undergoing percutaneous implantation of the aortic valve...
Two-year clinical outcome after coronary stenting of small vessels using 2.25-mm sirolimus- and paclitaxel-eluting stents: insight into the RESEARCH and T-SEARCH registriesShuzou Tanimoto
Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
Catheter Cardiovasc Interv 69:94-103. 2007..To evaluate long-term outcomes after drug-eluting stents (DES) implantation in small coronary vessels...
